ALBIO.PA PAR
Biosynex S.A.
1W: -3.4%
1M: +1.8%
3M: +0.9%
YTD: -13.7%
1Y: -23.9%
3Y: -89.9%
5Y: -93.9%
€0.84 ($0.94)
-0.06 (-6.90%)
Weekly Expected Move ±7.4%
€1
€1
€1
€1
€1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$195M
-19.5% ▼
5Y CAGR: +32.7%
Total Liabilities
$114M
-2.7% ▼
5Y CAGR: +46.4%
Shareholders Equity
$81M
-35.3% ▼
5Y CAGR: +21.5%
Cash & Investments
$10M
-63.0% ▼
5Y CAGR: +31.6%
Total Debt
$62M
-4.8% ▼
5Y CAGR: +44.3%
Net Debt
$58M
+27.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $37M | $132M | $87M | $20M | $5M |
| Short-Term Investments | $0 | $0 | $0 | $6M | $5M |
| Cash & ST Investments | $37M | $132M | $87M | $26M | $10M |
| Net Receivables | $11M | $25M | $15M | $11M | $11M |
| Inventory | $33M | $31M | $38M | $38M | $33M |
| Other Current Assets | $7M | $9M | $18M | $12M | $7M |
| Total Current Assets | $88M | $199M | $159M | $91M | $64M |
| Property, Plant & Equip. | $2M | $5M | $9M | $16M | $15M |
| Goodwill & Intangibles | $60M | $98M | $148M | $131M | $113M |
| Long-Term Investments | $2M | $10M | $5M | -$5M | $770K |
| Other Non-Current Assets | $3M | $2M | -$96M | $3M | $2M |
| Total Non-Current Assets | $39M | $70M | $101M | $150M | $130M |
| Total Assets | $126M | $269M | $260M | $242M | $195M |
| — Liabilities — | |||||
| Accounts Payable | $20M | $19M | $15M | $15M | $17M |
| Short-Term Debt | $6M | $6M | $7M | $5M | $47M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $14M | $29M | $8M | $14M | $5M |
| Total Current Liabilities | $46M | $61M | $39M | $41M | $86M |
| Long-Term Debt | $10M | $29M | $1M | $58M | $14M |
| Other Non-Current Liab. | $955K | $5M | $8M | $17M | $15M |
| Total Non-Current Liabilities | $11M | $48M | $10M | $77M | $28M |
| Total Liabilities | $60M | $101M | $93M | $117M | $114M |
| — Equity — | |||||
| Common Stock | $915K | $1M | $1M | $1M | $1M |
| Retained Earnings | $31M | $131M | $77M | $55M | $74M |
| Accumulated OCI | $6M | -$11M | $59M | $42M | -$20M |
| Total Stockholders Equity | $66M | $168M | $162M | $124M | $81M |
| Total Liabilities & Equity | $126M | $269M | $260M | $242M | $195M |
| — Key Metrics — | |||||
| Total Debt | $16M | $35M | $52M | $66M | $62M |
| Net Debt | -$21M | -$97M | -$35M | $45M | $58M |
| Total Investments | $2M | $10M | $5M | $675K | $6M |